We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Roche and Icagen have inked a licensing and collaboration deal around ion channel modulators for neurological disorders. The duo did not disclose Roche’s upfront payment or research funding......